David Owens Nexalin Technology, Inc. (NXL) insider trading activity
David Owens is Chief Medical Officer of Nexalin Technology, Inc.. Currently has a direct ownership of 155,793 shares of NXL, which is worth approximately $336,512. The most recent transaction as insider was on Feb 04, 2025, when has been sold 1,000 shares (Common Stock) at a price of $3.1 per share, resulting in proceeds of $3,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
156K
5.06%
3M change
10.36%
12M change
Total Value Held
$336,512
David Owens Transaction History
DO
David Owens
Chief Medical Officer
Atlanta, GA